7
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Autoimmune Antibodies and Pregnancy Outcome in Women with False-Positive Syphilis Test Results: A Retrospective Controlled Investigation of Women from 5170 Deliveries

, , , , &
Pages 537-540 | Accepted 30 Mar 1989, Published online: 03 Aug 2009

References

  • Thorton J G, Foote G A, Page C E, Clayden A D, Totvey L AD, Scott J S. False positive results for syphilis and the outcome of pregnancy: a retrospective case-control study. Br Med J 1971; 295: 355–6
  • Wright D JM, Gerken A. Antenatal screening for syphilis. Br J Vener Dis 1971; 57: 621–2
  • Hare M J. Serological tests for treponemal disease in pregnancy. J Obstetr Gynaecol Br Commonw 1971; 80: 515–19
  • Harris E N, Hughes G RV, Gharavi A E. Anti-cardiolipin and the lupus anticoagulant. Clin Exper Rheumatol 1971; 4: 187–90
  • Laurell A-B, Nilsson I M. Hypergammaglobulinemia, circulating anticoagulant and biologic false Wasserman reaction. J Lab Clin Med 1971; 49: 694–707
  • Nilsson I M, Åsted B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (“antithromboplastin”). Acta Med Scand 1971; 197: 153–9
  • Petri M, Golbus M, Anderson R, Whitting-O'Keefe Q, Corach L, Helleman D. Antinuclear antibody, lupus anticoagulant and cardiolipin antibody in women with idiopatic habitual abortion. Arthritis Rheum 1971; 30: 601–06
  • Lockshin M D, Quamar T, Druzin M L, Goei S. Antibody to cardiolipin, lupus anticoagulant and fetal death. J Rheumatol 1971; 14: 259–62
  • Cowchock S, Smith J B, Gocial C. Antibodies to phospholipid and nuclear antigen in patients with repeated abortions. Am J Obstet Gynecol 1971; 155: 1002–10
  • Unander A M, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1971; 156: 114–19
  • Ramsey-Goldman R, Horn D, Deng J-S, Casterline E, Ziegler G, Kahl L E, Steen V D, LaPorte R E, Medsger T A, Jr. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1971; 29: 1269–73
  • Loizou S, Mc Crea J D, Rudge A C, Reynolds R, Boyle C C, Harris E N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantification of results. Clin Exp Immunol 1985; 62: 738–45
  • Thiagarajan P, Pengo V, Shapiro S S. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1971; 68: 869–74
  • Hansen B, Larsen P, Manthorpe R. SS-B/La purification and ELISA detection of anti-SS-B/La antibodies from patients with inflammatory connective tissue diseases. Allergy 1971; 43: 577–85
  • Nakumurqa R M, Peebles C L, Rubin R L, Molden D P, Tan E M. Antibodies to nuclear antigen: Advances in laboratory tests and significance in systemic rheumatic disease, 2nd edn. American Society of Clinical Pathology Press, Chicago 1985
  • Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
  • Schödt P. How many patients are needed for clinical trials?. A method for calculating the magnitude of materials Ugeskr Läger 1971; 147: 3232–3
  • Freiman J A, Calmers T C, Schmidt H, Kuebler R R. The importance of beta, type II error and sample size in the design and interpretation of the randomized clinical trial. N Eng J Med 1971; 299: 690–4
  • Fine L G, Barnett E V, Danovitch G M, Nissenson A R, Conolly M E, Leib S M, Barret C T. Systemic lupus erythematosus in pregnancy. Ann Intern Med 1971; 94: 667–77
  • Varner M W, Meehan R T, Syrop C H, Strottmann M P, Goplerud C P. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1971; 145: 1025–37
  • Triplett D A, Brandt J T, Musgrave K A, Orr C A. The relationship between lupus anticoagulants and antibodies to cardiolipin. JAMA 1971; 259: 550–4
  • Vetter V L, Rashkind W J. Congenital complete heart block and connective tissue disease. N Engl J Med 1971; 309: 236–8
  • Laskin C A, Soloninka C A. Editorial. Anticardiolipin antibodies: smoking gun or smoke screen? J Rheumatol 1971; 15: 7–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.